Faecal microbiota transplantation in IBS — new evidence for success?

Nature Reviews Gastroenterology & Hepatology, Published online: 27 February 2020; doi:10.1038/s41575-020-0282-zFaecal microbiota transplantation (FMT) aims to restore an altered microbiota and has been suggested as a potential treatment option for irritable bowel syndrome (IBS), among other diseases. A new study suggests that the use of a so-called superdonor is necessary to successfully treat patients with IBS using FMT.
Source: Nature Reviews Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research